申请人:Sterling Drug Inc.
公开号:US04009170A1
公开(公告)日:1977-02-22
1-(2-Substituted-hydrazino)-3,4-dihydroisoquinolines, prepared in one process by alkylating the corresponding 3,4-dihydroisocarbostyrils, hydrazinolyzing the resulting 1-alkoxy-3,4-dihydroisoquinolines and condensing the resulting 1-hydrazIno-3,4-dihydroisoquinolines with aldehydes or ketones, and 1,1'-azinobis(1,2,3,4-tetrahydroisoquinolines), prepared by condensing corresponding 1-alkoxy-3,4-dihydroisoquinolines and 1-hydrazino-3,4-dihydroisoquinolines, are useful as antihypertensive agents and/or as antiinflammatory agents.
一种1-(2-取代基-肼基)-3,4-二氢异喹啉的制备方法,该方法通过烷基化相应的3,4-二氢异喹啉基酮,肼解所得的1-烷氧基-3,4-二氢异喹啉,并将所得的1-肼基-3,4-二氢异喹啉与醛或酮缩合而制得。另外,通过将相应的1-烷氧基-3,4-二氢异喹啉和1-肼基-3,4-二氢异喹啉缩合而制备出1,1'-异喹啉双(1,2,3,4-四氢异喹啉),该化合物可用作降压剂和/或抗炎剂。